Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells

Tissue Engineering - Part A

Volumn 18, Issue 13-14, 2012, Pages 1322-1333

  Serrao, Gregory W ^a   Turnbull, Irene C ^a   Ancukiewicz, Damian ^a   Kim, Do Eun ^b   Kao, Evan ^b   Cashman, Timothy J ^a   Hadri, Lahouaria ^a   Hajjar, Roger J ^a   Costa, Kevin D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Earth and Environmental Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOWCHARTING; HISTOLOGY; RATS; STEM CELLS; THREE DIMENSIONAL; TISSUE;

ANIMAL STUDIES; BASE-LINE CONDITIONS; CARDIAC FUNCTIONS; CARDIAC TISSUES; CARDIOMYOCYTES; CELL NUMBER; CLINICAL TRIAL; ELASTOMER MOLDS; EXPERIMENTAL GROUPS; FORCE SENSOR; IN-VITRO; MESENCHYMAL STEM CELL; MYOCYTES; NEONATAL RAT CARDIOMYOCYTES; STEM CELL THERAPY; THERAPEUTIC POTENTIALS; TYPE-I COLLAGEN;

ANIMAL CELL CULTURE;

ANIMALIA; RATTUS;

ANIMAL; ARTICLE; CELL COUNT; CYTOLOGY; DERMIS; FEMALE; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HEART MUSCLE; MECHANICAL STRESS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METHODOLOGY; MUSCLE CELL; RAT; SPRAGUE DAWLEY RAT; TIME; TISSUE ENGINEERING;

ANIMALS; CELL COUNT; DERMIS; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUSCLE CELLS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TIME FACTORS; TISSUE ENGINEERING;

EID: 84863896265     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0278     Document Type: Article

References (35)

1. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Adams, R.J., Berry, J.D., Brown, T.M., Carnethon, M.R., Dai, S., de Simone, G., Ford, E.S., Fox, C.S., Fullerton, H.J., Gillespie, C., Greenlund, K.J., Hailpern, S.M., Heit, J.A., Ho, P.M., Howard, V.J., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Makuc, D.M., Marcus, G.M., Marelli, A., Matchar, D.B., McDermott, M.M., Meigs, J.B., Moy, C.S., Mozaffarian, D., Mussolino, M.E., Nichol, G., Paynter, N.P., Rosamond, W.D., Sorlie, P.D., Stafford, R.S., Turan, T.N., Turner, M.B., Wong, N.D., and Wylie-Rosett, J. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18, 2011.
2. Hsieh, P.C., Segers, V.F., Davis, M.E., MacGillivray, C., Gannon, J., Molkentin, J.D., Robbins, J., and Lee, R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13, 970, 2007.
3. Thom, T., Kannel, W.B., Silbershatz, S., et al. Incidence, prevalence, and mortality of cardiovascular diseases in the United States. In: Alexander, R., Schlant, R.C., Fuster, V., and Roberts, R., eds. Hurst's The Heart, 4th edition. New York: McGraw Hill, 1998, pp. 3.
4. Murry, C.E., Field, L.J., and Menasche, P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112, 3174, 2005.
5. Williams, A.R., and Hare, J.M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109, 923, 2011.
6. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schworer, A., Uebeler, J., and Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ Res 107, 35, 2010.
7. Guterl, K.A., Haggart, C.R., Janssen, P.M., and Holmes, J.W. Isometric contraction induces rapid myocyte remodeling in cultured rat right ventricular papillary muscles. Am J Physiol Heart Circ Physiol 293, H3707, 2007.
8. Committee to revise the Guide for the Care and Use of Laboratory Animals; National Research Council. Guide for the Care and Use of Laboratory Animals, 8th edition. Washington, DC: National Academy Press, 1996.
9. Alhadlaq, A., and Mao, J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13, 436, 2004.
10. Legant, W.R., Pathak, A., Yang, M.T., Deshpande, V.S., McMeeking, R.M., and Chen, C.S. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc Natl Acad Sci USA 106, 10097, 2009.
11. Kim, D.E., Lee, E.J., Martens, T.P., Kara, R., Chaudhry, H.W., Itescu, S., and Costa, K.D. Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanisms. Conf Proc IEEE Eng Med Biol Soc 1, 849, 2006.
12. Fomovsky, G.M., and Holmes, J.W. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am J Physiol Heart Circ Physiol 298, H221, 2010.
13. Monasky, M.M., and Janssen, P.M. The positive forcefrequency relationship is maintained in absence of sarcoplasmic reticulum function in rabbit, but not in rat myocardium. J Comp Physiol B 179, 469, 2009.
14. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U., Weil, J., and Eschenhagen, T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68, 106, 2000.
15. Li, X., Yu, X., Lin, Q., Deng, C., Shan, Z., Yang, M., and Lin, S. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol 42, 295, 2007.
16. Xu, M., Wani, M., Dai, Y.S., Wang, J., Yan, M., Ayub, A., and Ashraf, M. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110, 2658, 2004.
17. Gyongyosi, M., Blanco, J., Marian, T., Tron, L., Petnehazy, O., Petrasi, Z., Hemetsberger, R., Rodriguez, J., Font, G., Pavo, I.J., Kertesz, I., Balkay, L., Pavo, N., Posa, A., Emri, M., Galuska, L., Kraitchman, D.L., Wojta, J., Huber, K., and Glogar, D. Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 1, 94, 2008.
18. Qi, C.M., Ma, G.S., Liu, N.F., Shen, C.X., Chen, Z., Liu, X.J., Hu, Y.P., Zhang, X.L., Teng, G.J., Ju, S.H., Ma, M., and Tang, Y.L. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model. Chin Med J (Engl) 121, 544, 2008.
19. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., Gerstenblith, G., DeMaria, A.N., Denktas, A.E., Gammon, R.S., Hermiller, J.B., Jr., Reisman, M.A., Schaer, G.L., and Sherman, W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54, 2277, 2009.
20. Chen, S.L., Fang, W.W., Ye, F., Liu, Y.H., Qian, J., Shan, S.J., Zhang, J.J., Chunhua, R.Z., Liao, L.M., Lin, S., and Sun, J.P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94, 92, 2004.
21. Williams, A.R., Trachtenberg, B., Velazquez, D.L., McNiece, I., Altman, P., Rouy, D., Mendizabal, A.M., Pattany, P.M., Lopera, G.A., Fishman, J., Zambrano, J.P., Heldman, A.W., and Hare, J.M. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 108, 792, 2011.
22. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., Feigenbaum, G.S., Rodriguez, J.E., Valdes, D., Pattany, P.M., Zambrano, J.P., Hu, Q., McNiece, I., Heldman, A.W., and Hare, J.M. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 106, 14022, 2009.
23. Hatzistergos, K.E., Quevedo, H., Oskouei, B.N., Hu, Q., Feigenbaum, G.S., Margitich, I.S., Mazhari, R., Boyle, A.J., Zambrano, J.P., Rodriguez, J.E., Dulce, R., Pattany, P.M., Valdes, D., Revilla, C., Heldman, A.W., McNiece, I., and Hare, J.M. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107, 913, 2010.
24. Numasawa, Y., Kimura, T., Miyoshi, S., Nishiyama, N., Hida, N., Tsuji, H., Tsuruta, H., Segawa, K., Ogawa, S., and Umezawa, A. Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells 29, 1405, 2011.
25. Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103, 1204, 2008.
26. Le Visage, C., Gournay, O., Benguirat, N., Hamidi, S., Chaussumier, L., Mougenot, N., Flanders, J.A., Isnard, R., Michel, J.B., Hatem, S., Letourneur, D., and Norol, F. Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Eng Part A 18, 35, 2012.
27. Dai, W., Hale, S.L., Martin, B.J., Kuang, J.Q., Dow, J.S., Wold, L.E., and Kloner, R.A. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112, 214, 2005.
28. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141, 2004.
29. Meyer, G.P., Wollert, K.C., Lotz, J., Pirr, J., Rager, U., Lippolt, P., Hahn, A., Fichtner, S., Schaefer, A., Arseniev, L., Ganser, A., and Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30, 2978, 2009.
30. Tiburcy, M., Didie, M., Boy, O., Christalla, P., Doker, S., Naito, H., Karikkineth, B.C., El-Armouche, A., Grimm, M., Nose, M., Eschenhagen, T., Zieseniss, A., Katschinksi, D.M., Hamdani, N., Linke, W.A., Yin, X., Mayr, M., and Zimmermann, W.H. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res 109, 1105, 2011.
31. Valiunas, V., Doronin, S., Valiuniene, L., Potapova, I., Zuckerman, J., Walcott, B., Robinson, R.B., Rosen, M.R., Brink, P.R., and Cohen, I.S. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol 555, 617, 2004.
32. Mills, W.R., Mal, N., Kiedrowski, M.J., Unger, R., Forudi, F., Popovic, Z.B., Penn, M.S., and Laurita, K.R. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 42, 304, 2007.
33. Chang, M.G., Tung, L., Sekar, R.B., Chang, C.Y., Cysyk, J., Dong, P., Marban, E., and Abraham, M.R. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 113, 1832, 2006.
34. Tse, H.F., Xue, T., Lau, C.P., Siu, C.W., Wang, K., Zhang, Q.Y., Tomaselli, G.F., Akar, F.G., and Li, R.A. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation 114, 1000, 2006.
35. Vandenburgh, H., Shansky, J., Benesch-Lee, F., Barbata, V., Reid, J., Thorrez, L., Valentini, R., and Crawford, G. Drugscreening platform based on the contractility of tissueengineered muscle. Muscle Nerve 37, 438, 2008.